- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 3/08 - Drugs for disorders of the metabolism for glucose homeostasis
Patent holdings for IPC class A61P 3/08
Total number of patents in this class: 1115
10-year publication summary
|
38
|
46
|
81
|
109
|
105
|
93
|
105
|
72
|
82
|
16
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Janssen Pharmaceutica N.V. | 3437 |
23 |
| Boehringer Ingelheim International GmbH | 4729 |
13 |
| The Board of Trustees of the Leland Stanford Junior University | 6284 |
13 |
| Axcess Global Sciences, LLC | 80 |
13 |
| Mymd Pharmaceuticals, Inc. | 32 |
11 |
| Sanofi-Aventis Deutschland GmbH | 2595 |
9 |
| Alla Chem, LLC | 55 |
9 |
| Société des Produits Nestlé S.A. | 9114 |
8 |
| Eli Lilly and Company | 3749 |
8 |
| The Regents of the University of California | 19661 |
7 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3353 |
7 |
| Regeneron Pharmaceuticals, Inc. | 4115 |
7 |
| Novo Nordisk A/S | 2251 |
7 |
| Amgen Inc. | 3961 |
6 |
| Ionis Pharmaceuticals, Inc. | 845 |
6 |
| The Salk Institute for Biological Studies | 444 |
6 |
| Hua Medicine (Shanghai) Ltd. | 59 |
6 |
| F. Hoffmann-La Roche AG | 7889 |
5 |
| Ajinomoto Co., Inc. | 2305 |
5 |
| Takeda Pharmaceutical Company Limited | 2702 |
5 |
| Other owners | 941 |